Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Cons...

Por Somlo, George, Frankel, Paul H., Arun, Banu K., Ma, Cynthia X., Garcia, Agustin A., Cigler, Tessa, Cream, Leah V., Harvey, Harold A., Sparano, Joseph A., Nanda, Rita, Chew, Helen K., Moynihan, Timothy J., Vahdat, Linda T., Goetz, Matthew P., Beumer, Jan H., Hurria, Arti, Mortimer, Joanne, Piekarz, Richard, Sand, Sharon, Herzog, Josef, Van Tongeren, Lily R., Ferry-Galow, Katherine V., Chen, Alice P., Ruel, Christopher, Newman, Edward M., Gandara, David R., Weitzel, Jeffrey N.
Publicado no Clin Cancer Res (2017)